ATE226638T1 - Retroviraler vektor und dessen verwendung in gentherapie - Google Patents

Retroviraler vektor und dessen verwendung in gentherapie

Info

Publication number
ATE226638T1
ATE226638T1 AT97901179T AT97901179T ATE226638T1 AT E226638 T1 ATE226638 T1 AT E226638T1 AT 97901179 T AT97901179 T AT 97901179T AT 97901179 T AT97901179 T AT 97901179T AT E226638 T1 ATE226638 T1 AT E226638T1
Authority
AT
Austria
Prior art keywords
retroviral vector
vector
gene therapy
reimplantation
transduced
Prior art date
Application number
AT97901179T
Other languages
English (en)
Inventor
Alan John Kingsman
Susan Mary Kingsman
Original Assignee
Oxford Biomedica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601336.2A external-priority patent/GB9601336D0/en
Priority claimed from GBGB9620759.2A external-priority patent/GB9620759D0/en
Application filed by Oxford Biomedica Ltd filed Critical Oxford Biomedica Ltd
Application granted granted Critical
Publication of ATE226638T1 publication Critical patent/ATE226638T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
AT97901179T 1996-01-23 1997-01-23 Retroviraler vektor und dessen verwendung in gentherapie ATE226638T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9601336.2A GB9601336D0 (en) 1996-01-23 1996-01-23 Retrovirus
GBGB9620759.2A GB9620759D0 (en) 1996-10-04 1996-10-04 Retrovirus
PCT/GB1997/000210 WO1997027310A1 (en) 1996-01-23 1997-01-23 Retroviral vector and its use in gene therapy

Publications (1)

Publication Number Publication Date
ATE226638T1 true ATE226638T1 (de) 2002-11-15

Family

ID=26308512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901179T ATE226638T1 (de) 1996-01-23 1997-01-23 Retroviraler vektor und dessen verwendung in gentherapie

Country Status (13)

Country Link
EP (1) EP0880594B1 (de)
JP (1) JP3535521B2 (de)
KR (1) KR19990087036A (de)
AT (1) ATE226638T1 (de)
AU (1) AU729934B2 (de)
CA (1) CA2243529A1 (de)
DE (1) DE69716581T2 (de)
DK (1) DK0880594T3 (de)
ES (1) ES2184059T3 (de)
NO (1) NO983375L (de)
NZ (1) NZ326429A (de)
PT (1) PT880594E (de)
WO (1) WO1997027310A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
WO1999058726A1 (en) * 1998-05-12 1999-11-18 Genecure Llc Replication defective hiv vaccine
US6958226B1 (en) 1998-09-11 2005-10-25 The Children's Medical Center Corp. Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins
CA2344208A1 (en) 2001-04-30 2002-10-30 Oxford Biomedica (Uk) Limited Method
KR20050111593A (ko) * 2003-02-19 2005-11-25 가부시키가이샤 디나벡크 겐큐쇼 허혈질환의 치료방법
GB0526211D0 (en) * 2005-12-22 2006-02-01 Oxford Biomedica Ltd Viral vectors
GB0920775D0 (en) 2009-11-26 2010-01-13 King S College Cells
GB201415344D0 (en) 2014-08-29 2014-10-15 Ucl Business Plc Protein
GB201603374D0 (en) 2016-02-26 2016-04-13 Ucl Business Plc Packaging cell

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834256A (en) * 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
FR2716459B1 (fr) * 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.

Also Published As

Publication number Publication date
CA2243529A1 (en) 1997-07-31
DE69716581T2 (de) 2003-03-06
NZ326429A (en) 2001-07-27
ES2184059T3 (es) 2003-04-01
AU729934B2 (en) 2001-02-15
JP3535521B2 (ja) 2004-06-07
NO983375L (no) 1998-09-21
EP0880594A1 (de) 1998-12-02
PT880594E (pt) 2003-03-31
DE69716581D1 (de) 2002-11-28
JP2000500986A (ja) 2000-02-02
DK0880594T3 (da) 2002-12-16
KR19990087036A (ko) 1999-12-15
EP0880594B1 (de) 2002-10-23
AU1452297A (en) 1997-08-20
WO1997027310A1 (en) 1997-07-31
NO983375D0 (no) 1998-07-22

Similar Documents

Publication Publication Date Title
DE69703974T2 (de) Retrovirale vektoren
ATE520783T1 (de) Lentivirale vektoren
DK0568537T3 (da) Genetisk modificering af endotelceller
EA199800566A1 (ru) Аденовирусный вектор (варианты), способ его получения, применение, репликационно-компетентное не содержащее аденовирус потомство, способ повышения размножения в комплементирующей клеточной линии аденовирусного вектора, способ генетической модификации клетки, композиция, клетка-хозяин, способ тестирования токсичности аденовирусного вектора, способ тестирования экспрессии чужеродного гена или гена-пассажира аденовирусного вектора
ATE298371T1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
CY1107760T1 (el) Κυτταρα φακοϊικου εγκλεισμου
ZA942778B (en) Recombinant viruses, and their preparation and use in gene therapy.
ATE226638T1 (de) Retroviraler vektor und dessen verwendung in gentherapie
AU2149099A (en) Pseudo-type retroviral vectors with modifiable surface capsid proteins
PT1212428E (pt) Redireccionamento da expressao do gene gama 34.5 de herpes atraves de um promotor especifico de celulas e/ou especifico de tumores
DE69534948D1 (de) Retrovirale vektoren zur expression in embryonalen zellen
ATE207963T1 (de) Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen
DE69942564D1 (de) Methoden und zusammensetzungen für die produktion von viruspartikeln
DE69737597D1 (de) Vektoren zur inhibierung von viralem und tumorwachstum
HUP9902585A2 (hu) Replikálódó molekulák in vivo előállítása
DE69535024D1 (de) Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren
ATE412764T1 (de) Genetische transduktion von hämatopoietische vorläuferzellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0880594

Country of ref document: EP

REN Ceased due to non-payment of the annual fee